Phase 3 Skin Clinical Trials
24 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–20 of 24 trials
Recruiting
Phase 3
Testing the Addition of an Immunotherapy Drug, Cemiplimab (REGN2810), Plus Surgery to the Usual Surgery Alone for Treating Advanced Skin Cancer
Stage III Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8Stage IV Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8Eyelid Squamous Cell Carcinoma+17 more
National Cancer Institute (NCI)420 enrolled206 locationsNCT06568172
Recruiting
Phase 2Phase 3
A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma
Unresectable MelanomaCutaneous MelanomaMelanoma (Skin Cancer)+1 more
Linnaeus Therapeutics, Inc.135 enrolled9 locationsNCT06624644
Recruiting
Phase 3
A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata
AlopeciaSkin DiseasesAreata Alopecia+3 more
Eli Lilly and Company595 enrolled127 locationsNCT05723198
Recruiting
Phase 3
NO Re-excision MelanomA - NORMA 2
Melanoma (Skin Cancer)
Marieke Goodijk1,749 enrolled21 locationsNCT07530887
Recruiting
Phase 3
Photodynamic Therapy Associated With Sonodynamic Therapy for the Treatment of Nodular Basal Cell Carcinoma
Nodular Basal Cell Carcinoma of Skin
University of Sao Paulo142 enrolled1 locationNCT07381972
Recruiting
Phase 3
Lidocaine Versus Diphenhydramine to Achieve Local Anesthesia for Laceration Repairs
Laceration of Skin
Florida Atlantic University100 enrolled1 locationNCT06910241
Recruiting
Phase 3
A Study to Learn About the Safety and Efficacy of the Drug Oleogel-S10 in Japanese Patients With Epidermolysis Bullosa
Skin DiseasesEpidermolysis BullosaConnective Tissue Disease+7 more
Chiesi Farmaceutici S.p.A.6 enrolled6 locationsNCT06917690
Recruiting
Phase 2Phase 3
DETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With HER2 Amplification or Activating Mutations
Ovarian NeoplasmsColorectal NeoplasmsUrinary Bladder Neoplasm+8 more
Cancer Research UK30 enrolled27 locationsNCT05786716
Recruiting
Phase 2Phase 3
Using a Contact Dermatitis Model With Biologic Medications to Study Skin Inflammation
Skin InflammationAllergic Contact Dermatitis
Wei-Che Ko45 enrolled1 locationNCT05535738
Recruiting
Phase 3
Modulating the Skin Microbiome to Prevent Radiation Dermatitis in Breast Cancer
Breast CancerSkin MicrobiomeRadiation Dermatitis
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University326 enrolled1 locationNCT07066280
Recruiting
Phase 3
Acetic Acid 2% Solution for Skin Ulcers
Ulcer, Skin
Consorci Sanitari de l'Alt Penedès i Garraf104 enrolled1 locationNCT06297967
Recruiting
Phase 3
Anxiolysis for Laceration Repair in Children
Distress, EmotionalLaceration of Skin
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's300 enrolled1 locationNCT05383495
Recruiting
Phase 3
Nicotinamide Chemoprevention for Keratinocyte Carcinoma in Solid Organ Transplant Recipients - Pivotal Trial
Carcinoma, Squamous CellNon-melanoma Skin CancerCarcinoma, Basal Cell+1 more
Women's College Hospital396 enrolled7 locationsNCT05955924
Recruiting
Phase 3
Undergraduate Skin Cancer Prevention Trial
Skin Cancer
University of Utah528 enrolled1 locationNCT05634252
Not Yet Recruiting
Phase 3
CICAPLAST Baume B5+: tolerability and observance of Topical 5% Fluorouracil in Patients diagnosed with Actinic Keratoses (AK)
Skin Cancer
The University of Queensland80 enrolled1 locationACTRN12624000911594
Completed
Phase 3
Effect of topical and oral Resveratrol on skin health, condition and visible signs of ageing, in healthy ageing females.
Skin healthVisible signs of skin ageingSkin condition - pores, sebum, wrinkle, pigment condition, moisture, elasticity, skin tone
and skin temperature
RDC Clinical Pty Ltd140 enrolled1 locationACTRN12621000709842
Recruiting
Phase 3
A comparison of two routinely used skin treatments for women with breast cancer undergoing radiation therapy
Acute radiation therapy (RT) skin toxicity and managementBreast Cancer
Western Sydney Local Health District60 enrolled3 locationsACTRN12619000753156
Completed
Phase 3Phase 4
Fiji Northern Division Ivermectin Mass Drug Administration for Scabies Trial
Post streptococcal glomerulonephritisInvasive group A streptococcal infectionsSkin and soft tissue infections+3 more
Murdoch Children's Research Insititute135,000 enrolled1 locationACTRN12618000461291
Terminated
Phase 2Phase 3
Does Mepitel Film decrease skin reactions caused by radiation therapy in head and neck cancer patients?
Acute radiation-induced skin reactionsHead and Neck Cancer
Otago University86 enrolled2 locationsACTRN12616000725460
Completed
Phase 2Phase 3
A randomized, placebo-controlled, double blind, parallel design study of Xolair (omalizumab) for the management of treatment-resistant systemic and cutaneous mastocytosis.
Systemic mastocytosisMastocytosis in the skin
Novartis Pharmaceuticals30 enrolled1 locationACTRN12613001096741